Cart
sales@molnova.com
REV 5901A
CAS No. 92532-23-5
REV 5901A( —— )
Catalog No. M33762 CAS No. 92532-23-5
REV 5901A (REV 5901 HCl) is an orally active leukotriene receptor antagonist and 5-lipoxygenase inhibitor with antimicrobial activity that attenuates colon cancer growth in mice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 163 | In Stock |
|
| 5MG | 276 | In Stock |
|
| 10MG | 394 | In Stock |
|
| 25MG | 616 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameREV 5901A
-
NoteResearch use only, not for human use.
-
Brief DescriptionREV 5901A (REV 5901 HCl) is an orally active leukotriene receptor antagonist and 5-lipoxygenase inhibitor with antimicrobial activity that attenuates colon cancer growth in mice.
-
DescriptionREV 5901A (REV 5901 HCl) is an orally active leukotriene receptor antagonist and 5-lipoxygenase inhibitor with antimicrobial activity that attenuates colon cancer growth in mice.REV 5901A has been used in studies of asthma and myocardial infarction. REV 5901A is used to study asthma and myocardial infarction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
RecptorAntibiotic | Lipoxygenase | Leukotriene Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number92532-23-5
-
Formula Weight371.9
-
Molecular FormulaC22H26ClNO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.OC(C=1C=CC=C(OCC2=NC=3C=CC=CC3C=C2)C1)CCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Silver sulfadiazine
It is a topical antibiotic used in partial thickness and full thickness burns to prevent infection.
-
Phleomycin
Phleomycin is one of the anticancer glycopeptide antibiotics which cause DNA cleavage.
-
Benznidazole
Benznidazole has an antiprotozoal activity by interfering with parasite protein biosynthesis influencing cytokines production and stimulating host phagocytosis.
